newsfilter
← Latest News
GlobeNewswire·

Interpace Biosciences Announces Record First Quarter 2023 Financial and Business Results

●Q1 Revenue of $9.8 million; a 24% increase year-over-year; highest quarter in history ●Q1 Test volume up nearly 20% year over year to record levels ●Q1 41.9 million covered lives added, resulting from 8 new or updated